Intellia Therapeutics (NASDAQ:NTLA) Rating Increased to Outperform at William Blair

Markets Rebound After Initial Selloff Triggered by Middle East Tensions

Robinhood joins biggest S&P500 losers list

Candid scores Nasdaq listing via reverse merger Rallybio

BioCryst Pharmaceuticals (BCRX) Is Up 15.4% After First Profitable Year And HAE Portfolio Expansion - Has The Bull Case Changed?

Nasdaq follows Cboe joining world of 'binary bets' as prediction market craze hits Wall Street